Yubo International Biotech (OTCMKTS:YBGJ – Get Free Report) and Precision Optics (NASDAQ:POCI – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, profitability, dividends, institutional ownership, valuation, analyst recommendations and risk.
Valuation & Earnings
This table compares Yubo International Biotech and Precision Optics’ top-line revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Yubo International Biotech | $100,000.00 | 644.08 | -$1.21 million | N/A | N/A |
| Precision Optics | $20.81 million | 1.78 | -$930,000.00 | $0.10 | 61.00 |
Precision Optics has higher revenue and earnings than Yubo International Biotech.
Profitability
| Net Margins | Return on Equity | Return on Assets | |
| Yubo International Biotech | -341.37% | N/A | -32.26% |
| Precision Optics | 2.07% | -3.33% | -1.79% |
Insider & Institutional Ownership
17.4% of Precision Optics shares are owned by institutional investors. 56.5% of Yubo International Biotech shares are owned by company insiders. Comparatively, 22.7% of Precision Optics shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
Volatility & Risk
Yubo International Biotech has a beta of 5.27, suggesting that its stock price is 427% more volatile than the S&P 500. Comparatively, Precision Optics has a beta of 0.38, suggesting that its stock price is 62% less volatile than the S&P 500.
Analyst Ratings
This is a summary of recent ratings and recommmendations for Yubo International Biotech and Precision Optics, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Yubo International Biotech | 0 | 0 | 0 | 0 | N/A |
| Precision Optics | 0 | 0 | 0 | 0 | N/A |
Summary
Precision Optics beats Yubo International Biotech on 5 of the 9 factors compared between the two stocks.
About Yubo International Biotech
Yubo International Biotech Limited, through its subsidiaries, focuses on the research and development, and application of endometrial stem cells. It offers healthcare products for respiratory system, skincare products, hair care products, healthy beverages, and male and female personal care products; and stem cell related services, including cell testing and health management consulting services under the VIVCELL brand. The company is headquartered in Beijing, China.
About Precision Optics
Precision Optics Corporation, Inc. designs, develops, manufactures, and sells specialized optical and illumination systems and related components primarily in the United States and the European Economic Area. It offers medical instrumentation products, including endoscopes and endocouplers, as well as other custom imaging and illumination products, such as Microprecision lenses and micro medical cameras, and 3D endoscopes for use in minimally invasive surgical procedures by hospitals and physicians. The company also provides components and assemblies for industrial and military use. It markets its products to medical device companies. The company was incorporated in 1982 and is based in Gardner, Massachusetts.
Receive News & Ratings for Yubo International Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Yubo International Biotech and related companies with MarketBeat.com's FREE daily email newsletter.
